A quantitative analysis of the effect of cycle length on arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts

Pflugers Archiv European Journal of Physiology

Volumn 454, Issue 6, 2007, Pages 925-936

  Sabir, Ian N ^a   Fraser, James A ^a   Cass, Thomas R ^a   Grace, Andrew A ^a   Huang, Christopher L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Action potential duration; Arrhythmia; Critical angle; Cycle length; Heart rate; Re excitation; Refractory period

Indexed keywords

LIDOCAINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; ELECTROSTIMULATION; EXTRASYSTOLE; HEART ARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE CONDUCTION; HYPOKALEMIA; ISOLATED HEART; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFRACTORY PERIOD; STATISTICAL ANALYSIS;

ACTION POTENTIALS; ALGORITHMS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; ELECTRIC STIMULATION; HEART; HEART RATE; HEART VENTRICLES; HYPOKALEMIA; LIDOCAINE; MEMBRANE POTENTIALS; MICE; PERFUSION; PERICARDIUM; POTASSIUM; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL;

EID: 34548320841     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0255-x     Document Type: Article

References (58)

1. Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, Nademanee K (2003) Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 41:1665-1671
2. Balasubramaniam R, Grace AA, Saumarez RC, Vandenberg JI, Huang CL (2003) Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 552:535-546
3. Bevington PR (1969) Data reduction and error analysis for the physical sciences. McGraw-Hill, New York
4. Casimiro MC, Knollmann BC, Ebert SN, Vary JC Jr, Greene AE, Franz MR, Grinberg A, Huang SP, Pfeifer K (2001) Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci USA 98:2526-2531
5. Cerrone M, Colombi B, Santoro M, di Barletta MR, Scelsi M, Villani L, Napolitano C, Priori SG (2005) Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 96:e77-e82
6. Chinushi M, Kasai H, Tagawa M, Washizuka T, Hosaka Y, Chinushi Y, Aizawa Y (2002) Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes. J Am Coll Cardiol 40:555-562
7. Costard-Jaeckle A, Liem LB, Franz MR (1989) Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo. J Cardiovasc Pharmacol 14:810-817
8. Danik S, Cabo C, Chiello C, Kang S, Wit AL, Coromilas J (2002) Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart. Am J Physiol Heart Circ Physiol 283:H372-H381
9. Davy JM, Weissenburger J, Ertzbischoff O, Lainee P, Chezalviel F, Poirier JM, Cheymol G, Motte G (1988) Sotalol-induced torsades de pointe in the conscious dog with atrioventricular block. Role of hypokalemia. Arch Mal Coeur Vaiss 81:1117-1124
10. el-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R (1988) QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias. Circ Res 63:286-305
11. Fabritz L, Kirchhof P, Franz MR, Eckardt L, Monnig G, Milberg P, Breithardt G, Haverkamp W (2003) Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 98:25-32
12. Fabritz L, Kirchhof P, Franz MR, Nuyens D, Rossenbacker T, Ottenhof A, Haverkamp W, Breithardt G, Carmeliet E, Carmeliet P (2003) Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in ΔKPQ SCN5A (long QT3) mice. Cardiovasc Res 57:1085-1093
13. Franz MR, Chin MC, Sharkey HR, Griffin JC, Scheinman MM (1990) A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo. J Am Coll Cardiol 16:878-886
14. + current diversity in mouse ventricular myocytes. J Physiol 521:587-599
15. Head CE, Balasubramaniam R, Thomas G, Goddard CA, Lei M, Colledge WH, Grace AA, Huang CL (2005) Paced electrogram fractionation analysis of arrhythmogenic tendency in ΔKPQ SCN5A mice. J Cardiovasc Electrophysiol 16:1329-1340
16. Higuchi T, Nakaya Y (1984) T wave polarity related to the repolarization process of epicardial and endocardial ventricular surfaces. Am Heart J 108:290-295
17. Killeen M, Thomas G, Gurung I, Goddard C, Fraser J, Mahaut-Smith M, Colledge H, Grace A, Huang C (2006) Arrhythmogenic mechanisms in the isolated perfused hypokalemic murine heart. Acta Physiologica 189:33-46
18. Kirchhof P, Degen H, Franz MR, Eckardt L, Fabritz L, Milberg P, Laer S, Neumann J, Breithardt G, Haverkamp W (2003) Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation. J Pharmacol Exp Ther 305:257-263
19. Knollmann BC, Katchman AN, Franz MR (2001) Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12:1286-1294
20. Koller BS, Karasik PE, Solomon AJ, Franz MR (1995) Relation between repolarization and refractoriness during programmed electrical stimulation in the human right ventricle. Implications for ventricular tachycardia induction. Circulation 91:2378-2384
21. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 81:627-635
22. Liu G, Iden JB, Kovithavongs K, Gulamhusein R, Duff HJ, Kavanagh KM (2004) In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave. J Physiol 555:267-279
23. Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG (2006) Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 99:292-298
24. London B (2001) Cardiac arrhythmias: from (transgenic) mice to men. J Cardiovasc Electrophysiol 12:1089-1091
25. Lubinski A, Lewicka-Nowak E, Kempa M, Baczynska AM, Romanowska I, Swiatecka G (1998) New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin Electrophysiol 21:172-175
26. Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W (2002) Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. J Pharmacol Exp Ther 303:218-225
27. Milberg P, Reinsch N, Wasmer K, Monnig G, Stypmann J, Osada N, Breithardt G, Haverkamp W, Eckardt L (2005) Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3. Cardiovasc Res 65:397-404
28. Morissette P, Hreiche R, Turgeon J (2005) Drug-induced long QT syndrome and torsade de pointes. Can J Cardiol 21:857-864
29. Nakaya Y, Nii H, Nomura M, Fujino K, Mori H (1989) Effects of lidocaine and quinidine on post-repolarization refractoriness after the basic and premature action potentials: consideration of aim of antiarrhythmic drug therapy. Am Heart J 118:907-912
30. Nemec J, Buncova M, Bulkova V, Hejlik J, Winter B, Shen WK, Ackerman MJ (2004) Heart rate dependence of the QT interval duration: differences among congenital long QT syndrome subtypes. J Cardiovasc Electrophysiol 15:550-556
31. + channel diversity in the mammalian myocardium. J Physiol 525:285-298
32. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH, Grace AA (2002) Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci USA 99:6210-6215
33. Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA (2005) Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 42:863-870
34. Rehnqvist N, Ericsson CG, Eriksson S, Olsson G, Svensson G (1984) Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction. Acta Med Scand 216:525-530
35. Rentschler S, Vaidya DM, Tamaddon H, Degenhardt K, Sassoon D, Morley GE, Jalife J, Fishman GI (2001) Visualization and functional characterization of the developing murine cardiac conduction system. Development 128:1785-1792
36. Roden DM, Hoffman BF (1985) Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. Circ Res 56:857-867
37. Sabir IN, Fraser JA, Killeen MJ, Grace AA, Huang C (2007) The contribution of refractoriness to arrhythmic substrate in hypokalemic Langendorff-perfused murine hearts. Pflugers Arch PMID: 17295037 (Electronic publication ahead of print)
38. Sabir IN, Killeen MJ, Goddard CA, Thomas G, Gray S, Grace AA, Huang CL (2007) Transient alterations in transmural repolarization gradients following premature ventricular depolarizations in arrhythmogenic hypokalemic Langendorff-perfused murine hearts. J Physiol PMID:17331992 (Electronic publication ahead of print)
39. Salama G, London B (2007) Mouse models of long QT syndrome. J Physiol 578:43-53
40. Satoh Y, Sugiyama A, Chiba K, Tamura K, Hashimoto K (2000) QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring. J Cardiovasc Pharmacol 36:510-515
41. Satoh Y, Sugiyama A, Tamura K, Hashimoto K (2000) Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential. Jpn Circ J 64:445-451
42. Saumarez RC, Pytkowski M, Sterlinski M, Hauer RN, Derksen R, Lowe MD, Szwed H, Huang CL, Ward DE, Camm AJ, Grace AA (2006) Delayed paced ventricular activation in the long QT syndrome is associated with ventricular fibrillation. Heart Rhythm 3:771-778
43. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95
44. Shimizu W, Antzelevitch C (1997) Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 96:2038-2047
45. Shimizu W, Tanaka K, Suenaga K, Wakamoto A (1991) Bradycardia-dependent early afterdepolarizations in a patient with QTU prolongation and torsade de pointes in association with marked bradycardia and hypokalemia. Pacing Clin Electrophysiol 14:1105-1111
46. Stokoe KS, Balasubramaniam R, Goddard CA, Colledge WH, Grace AA, Huang CL (2007) Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts. J Physiol PMID:17303635 (Electronic publication ahead of print
47. Stokoe KS, Thomas G, Goddard CA, Colledge WH, Grace AA, Huang CL (2007) Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Δ murine hearts modelling long QT syndrome 3. J Physiol 578:69-84
48. Sugiyama A, Satoh Y, Shiina H, Takeda S, Hashimoto K (2002) Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models. J Cardiovasc Pharmacol 40:235-245
49. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I (2003) Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89:66-70
50. Swynghedauw B, Baillard C, Milliez P (2003) The long QT interval is not only inherited but is also linked to cardiac hypertrophy. J Mol Med 81:336-345
51. 2+ channel antagonism on ventricular arrhythmogenesis in ΔKPQ Scn5a (long QT 3) murine hearts. J Physiol 578:85-97
52. Thomas G, Killeen MJ, Gurung IS, Hakim P, Balasubramaniam RN, Goddard CA, Grace AA, Huang CL (2006) Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1. J Physiol 578:97-114
53. Vaidya D, Morley GE, Samie FH, Jalife J (1999) Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ Res 85:174-181
54. Vandenberg CA (1987) Inward rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc Natl Acad Sci USA 84:2560-2564
55. Viskin S (2000) Cardiac pacing in the long QT syndrome: review of available data and practical recommendations. J Cardiovasc Electrophysiol 11:593-600
56. Voigt L, Coromilas J, Saul BI, Kassotis J (2003) Amiodarone-induced torsade de pointes during bladder irrigation: an unusual presentation-a case report. Angiology 54:229-231
57. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC, Wellens HJ (1995) Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 91:864-872
58. Yang T, Roden DM (1996) Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. Circulation 93:407-411